Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice
The article outlines aspects of the current state of the problem of the priority choice of an oral anticoagulant for indefinite prevention of stroke and systemic thromboembolism in patients with atrial fibrillation.The advantages of direct oral angicoagulants over warfarin are presented, as well as a comparative analysis of the individual character